The role of renin-angiotensin-aldosterone system genes in the progression of chronic kidney disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) study

Nephrology Dialysis Transplantation

Volumn 30, Issue 10, 2015, Pages 1711-1718

  Kelly, Tanika N ^a   Raj, Dominic ^b   Rahman, Mahboob ^c   Kretzler, Matthias ^d   Kallem, Radhakrishna R ^e   Ricardo, Ana C ^f   Rosas, Sylvia E ^g   Tao, Kaixiang ^h   Xie, Dawei ^h   Hamm, Lotuce Lee ⁱ   He, Jiang ^a,i  

^a TULANE UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic kidney disease; genetics; renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSINOGEN; BIOLOGICAL MARKER;

ADULT; AGT GENE; ARTICLE; BLACK PERSON; CAUCASIAN; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENBP GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; GENETICS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; RENIN-ANGIOTENSIN SYSTEM; YOUNG ADULT;

EID: 84943382196     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv125     Document Type: Article

References (36)

1. US Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2013
2. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
3. McClellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 2003; 14: S65-S70
4. Peterson JC, Adler S, Burkart JM, et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995; 123: 754-762
5. Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278: 2069-2074
6. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334: 13-18
7. Cowie CC, Port FK, Wolfe RA, et al. Disparities in incidence of diabetic endstage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074-1079
8. Parsa A, Kao WHL, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369: 2183-2196
9. Remuzzi G, Perico N, MaciaMet al. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl 2005; 99: S57-S65
10. Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin II and renal fibrosis. Hypertension 2001; 38: 635-638
11. Hsu CC-C, Bray MS, Kao WHL, et al. Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. J Am Soc Nephrol 2006; 17: 504-512
12. Anbazhagan K, Sampathkumar K, RamakrishnanMet al. Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients. Clin Chim Acta 2009; 406: 108-112
13. Buraczynska M, Ksiazek P, Drop A, et al. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant 2006; 21: 979-983
14. Campbell C, Fang B, Guo X, et al. Associations between genetic variants in the ACE, AGT, AGTR1 and AGTR2 genes and renal function in the Multiethnic Study of Atherosclerosis. Am J Nephrol 2010; 32: 156-162
15. Prasad P, Tiwari A, Kumar K, et al. Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 2006; 7: 42
16. Rudnicki M, Mayer G. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. Pharmacogenomics 2009; 10: 463-476
17. Tripathi G, Dharmani P, Khan F, et al. High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMCNephrol 2006; 7: 15
18. Wong C, Kanetsky P, Raj D. Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease. Pediatr Nephrol 2008; 23: 1037-1051
19. Feldman HI, Appel LJ, Chertow GMet al. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 2003; 14: S148-S153
20. Lash JP, Go AS, Appel LJ, et al. Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 2009; 4: 1302-1311
21. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470
22. Anderson AH, Yang W, Hsu C-Y, et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2012; 60: 250-261
23. Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS ONE 2008; 3: e3583
24. Price AL, Patterson NJ, PlengeRMet al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909
25. Ma L, Clark AG, Keinan A. Gene-based testing of interactions in association studies of quantitative traits. PLoS Genet 2013; 9: e1003321
26. Zaykin D, Zhivotovsky L, Westfall P, et al. Truncated product method for combining p-values. Genet Epidemiol 2002; 22: 170-185
27. Sheng X, Yang J. Truncated product methods for panel unit root tests. Oxf Bull Econ Stat 2013; 75: 624-636
28. Yang J, Zhu Y, Cole SA, et al. A gene-family analysis of 61 genetic variants in the nicotinic acetylcholine receptor genes for insulin resistance and type 2 diabetes in American Indians. Diabetes 2012; 61: 1888-1894
29. Yang J, Zhu Y, Lee ET, et al. Joint associations of 61 genetic variants in the nicotinic acetylcholine receptor genes with subclinical atherosclerosis in American Indians: a gene-family analysis. Circ Cardiovasc Genet 2013; 6: 89-96
30. Lovati E, Richard A, Frey BM, et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001; 60: 46-54
31. Knoll A, Schunkert H, Reichwald K, et al. Human renin binding protein: complete genomic sequence and association of an intronic T/C polymorphism with the prorenin level in males. Hum Mol Genet 1997; 6: 1527-1534
32. Gu D, Kelly TN, Hixson JE, et al. Genetic polymorphisms in the renin-angiotensin-aldosterone system and salt-sensitivity of blood pressure. J Hypertens 2010; 28: 1210-1220
33. Donaghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: e1-e9
34. Santos RA. Angiotensin-(1-7) Hypertension 2014; 63: 1138-1147
35. Yang M, Zhao J, Xing L, et al. The association between angiotensinconverting enzyme 2 polymorphisms and essential hypertension risk: a meta-analysis involving 14, 122 patients. J Renin-Angiotensin-Aldosterone Syst 2014; doi: 10.1177/1470320314549221
36. Malard L, Kakinami L, O'Loughlin J, et al. The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort of adolescents. BMC Med Genet 2013; 14: 117